NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 166 filers reported holding NOVAVAX INC in Q3 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $21,000 | -27.6% | 11,214 | -27.9% | 0.00% | 0.0% |
| Q3 2018 | $29,000 | +38.1% | 15,561 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $21,000 | -34.4% | 15,561 | +1.1% | 0.00% | 0.0% |
| Q1 2018 | $32,000 | +68.4% | 15,399 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $19,000 | +26.7% | 15,399 | +15.5% | 0.00% | 0.0% |
| Q3 2017 | $15,000 | -89.2% | 13,334 | -89.0% | 0.00% | -83.3% |
| Q2 2017 | $139,000 | -9.7% | 120,775 | +0.4% | 0.01% | -14.3% |
| Q1 2017 | $154,000 | -6.7% | 120,320 | -7.9% | 0.01% | -12.5% |
| Q4 2016 | $165,000 | -46.6% | 130,691 | -12.0% | 0.01% | -46.7% |
| Q3 2016 | $309,000 | -72.2% | 148,443 | -2.9% | 0.02% | -72.2% |
| Q2 2016 | $1,112,000 | +35.1% | 152,936 | -4.1% | 0.05% | +25.6% |
| Q1 2016 | $823,000 | -50.2% | 159,406 | -19.0% | 0.04% | -44.9% |
| Q4 2015 | $1,651,000 | +18.4% | 196,760 | -0.2% | 0.08% | -1.3% |
| Q3 2015 | $1,394,000 | +1664.6% | 197,157 | +1045.9% | 0.08% | +2533.3% |
| Q2 2014 | $79,000 | +8.2% | 17,205 | +6.2% | 0.00% | 0.0% |
| Q1 2014 | $73,000 | – | 16,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |